BeiGene
BGNE
#881
Rank
C$30.08 B
Marketcap
$273.98
Share price
1.71%
Change (1 day)
5.47%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Stock price history for BeiGene (BGNE)

Highest end of day price: $546.82 CAD on 2021-09-17

Lowest end of day price: $32.53 CAD on 2016-02-12

Stock price history of BeiGene from 2016 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$1.35-0.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.01-6.92%๐Ÿ‡บ๐Ÿ‡ธ USA